. Referanser

Abou-Alfa, G. K., Geschwind, J. F., Choti, M., & d'Angelica, M. I. (2015). Consensus conference on intrahepatic cholangiocarcinoma. HPB, 17(8), 661-663. https://doi.org/10.1111/hpb.12438

Ali, A. H., Tabibian, J. H., Nasser-Ghodsi, N., Lennon, R. J., DeLeon, T., Borad, M. J., . . . Lindor, K. D. (2018). Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis. Hepatology, 67(6), 2338-2351. https://doi.org/10.1002/hep.29730

Aloia, T. A., Járufe, N., Javle, M., Maithel, S. K., Roa, J. C., Adsay, V., . . . Jarnagin, W. R. (2015). Gallbladder cancer: expert consensus statement. HPB, 17(8), 681-690. https://doi.org/10.1111/hpb.12444

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. (1992). Critical Care Medicine, 20(6), 864-874.

Averbukh, L. D., Wu, D. C., Cho, W. C., & Wu, G. Y. (2019). Biliary Mucinous Cystadenoma: A Review of the Literature. Journal of clinical and translational hepatology, 7(2), 149-153. https://doi.org/10.14218/jcth.2019.00017

Badshah, M. B., Vanar, V., Kandula, M., Kalva, N., Badshah, M. B., Revenur, V., . . . Puli, S. R. (2019). Peroral cholangioscopy with cholangioscopy-directed biopsies in the diagnosis of biliary malignancies: a systemic review and meta-analysis. European Journal of Gastroenterology and Hepatology, 31(8), 935-940. https://doi.org/10.1097/meg.0000000000001402

Bagante, F., Gani, F., Spolverato, G., Xu, L., Alexandrescu, S., Marques, H. P., . . . Pawlik, T. M. (2015). Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy. Journal of the American College of Surgeons, 221(6), 1031-1040.e1031-1034. https://doi.org/10.1016/j.jamcollsurg.2015.09.012

Bartsch, F., Eberhard, J., Rückert, F., Schmelzle, M., Lehwald-Tywuschik, N., Fichtner-Feigl, S., . . . Lang, H. (2021). Repeated resection for recurrent intrahepatic cholangiocarcinoma: A retrospective German multicentre study. Liver international, 41(1), 180-191. https://doi.org/10.1111/liv.14682

Bowlus, C. L., Lim, J. K., & Lindor, K. D. (2019). AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review. Clinical Gastroenterology and Hepatology, 17(12), 2416-2422. https://doi.org/10.1016/j.cgh.2019.07.011

Bridgewater, J., Fletcher, P., Palmer, D. H., Malik, H. Z., Prasad, R., Mirza, D., . . . Primrose, J. (2022). Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study. Journal of Clinical Oncology, 40(18), 2048-2057. https://doi.org/10.1200/jco.21.02568

Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J. W., Patel, T., . . . Gores, G. J. (2014). Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. Journal of Hepatology, 60(6), 1268-1289. https://doi.org/10.1016/j.jhep.2014.01.021

Brudvik, K. W., Yaqub, S., Kemsley, E., Coolsen, M. M. E., Dejong, C. H. C., Wigmore, S. J., & Lassen, K. (2019). Survey of the attitudes of hepatopancreatobiliary surgeons in northern Europe to resection of choledochal cysts in asymptomatic Western adults. BJS open, 3(6), 785-792. https://doi.org/10.1002/bjs5.50208

Buettner, S., Ten Cate, D. W. G., Bagante, F., Alexandrescu, S., Marques, H. P., Lamelas, J., . . . Koerkamp, B. G. (2019). Survival after Resection of Multiple Tumor Foci of Intrahepatic Cholangiocarcinoma. Journal of Gastrointestinal Surgery, 23(11), 2239-2246. https://doi.org/10.1007/s11605-019-04184-2

Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010). Diagnosis and management of primary sclerosing cholangitis. Hepatology, 51(2), 660-678. https://doi.org/10.1002/hep.23294

Clements, O., Eliahoo, J., Kim, J. U., Taylor-Robinson, S. D., & Khan, S. A. (2020). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Journal of Hepatology, 72(1), 95-103. https://doi.org/10.1016/j.jhep.2019.09.007

Conci, S., Ruzzenente, A., Viganò, L., Ercolani, G., Fontana, A., Bagante, F., . . . Guglielmi, A. (2018). Patterns of Distribution of Hepatic Nodules (Single, Satellites or Multifocal) in Intrahepatic Cholangiocarcinoma: Prognostic Impact After Surgery. Annals of Surgical Oncology, 25(12), 3719-3727. https://doi.org/10.1245/s10434-018-6669-1

Di Martino, M., Koh, Y. X., Syn, N., Min Chin, K., Fernando, B., Sánchez Velázquez, P., . . . Ielpo, B. (2022). It is the lymph node ratio that determines survival and recurrence patterns in resected distal cholangiocarcinoma. A multicenter international study. European Journal of Surgical Oncology, 48(7), 1576-1584. https://doi.org/10.1016/j.ejso.2022.02.008

Doebele, R. C., Drilon, A., Paz-Ares, L., Siena, S., Shaw, A. T., Farago, A. F., . . . Demetri, G. D. (2020). Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. Lancet Oncology, 21(2), 271-282. https://doi.org/10.1016/s1470-2045(19)30691-6

EASL Clinical Practice Guidelines on sclerosing cholangitis. (2022). Journal of Hepatology, 77(3), 761-806. https://doi.org/10.1016/j.jhep.2022.05.011

Ebata, T., Mizuno, T., Yokoyama, Y., Igami, T., Sugawara, G., & Nagino, M. (2018). Surgical resection for Bismuth type IV perihilar cholangiocarcinoma. British Journal of Surgery, 105(7), 829-838. https://doi.org/10.1002/bjs.10556

Edeline, J., Benabdelghani, M., Bertaut, A., Watelet, J., Hammel, P., Joly, J. P., . . . Phelip, J. M. (2019). Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study. Journal of Clinical Oncology, 37(8), 658-667. https://doi.org/10.1200/jco.18.00050

Edeline, J., Lamarca, A., McNamara, M. G., Jacobs, T., Hubner, R. A., Palmer, D., . . . Valle, J. W. (2021). Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis. Cancer Treatment Reviews, 99, 102258. https://doi.org/10.1016/j.ctrv.2021.102258

Edeline, J., Touchefeu, Y., Guiu, B., Farge, O., Tougeron, D., Baumgaertner, I., . . . Garin, E. (2020). Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. JAMA oncology, 6(1), 51-59. https://doi.org/10.1001/jamaoncol.2019.3702

Esnaola, N. F., Meyer, J. E., Karachristos, A., Maranki, J. L., Camp, E. R., & Denlinger, C. S. (2016). Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer, 122(9), 1349-1369. https://doi.org/10.1002/cncr.29692

Ettel, M., Eze, O., & Xu, R. (2015). Clinical and biological significance of precursor lesions of intrahepatic cholangiocarcinoma. World Journal of Hepatology, 7(25), 2563-2570. https://doi.org/10.4254/wjh.v7.i25.2563

Foley, K. G., Lahaye, M. J., Thoeni, R. F., Soltes, M., Dewhurst, C., Barbu, S. T., . . . Roberts, S. A. (2022). Management and follow-up of gallbladder polyps: updated joint guidelines between the ESGAR, EAES, EFISDS and ESGE. European Radiology, 32(5), 3358-3368. https://doi.org/10.1007/s00330-021-08384-w

Forskrift om prioritering av helsetjenester, rett til nødvendig helsehjelp fra spesialisthelsetjenesten, rett til behandling i utlandet og om klagenemnd (prioriteringsforskriften). (2000). FOR-2000-12-01-1208. Hentet fra https://lovdata.no/dokument/SF/forskrift/2000-12-01-1208

Gerges, C., Beyna, T., Tang, R. S. Y., Bahin, F., Lau, J. Y. W., van Geenen, E., . . . Ramchandani, M. (2020). Digital single-operator peroral cholangioscopy-guided biopsy sampling versus ERCP-guided brushing for indeterminate biliary strictures: a prospective, randomized, multicenter trial (with video). Gastrointestinal Endoscopy, 91(5), 1105-1113. https://doi.org/10.1016/j.gie.2019.11.025

Giuliante, F., Ardito, F., Guglielmi, A., Aldrighetti, L., Ferrero, A., Calise, F., . . . Nuzzo, G. (2016). Association of Lymph Node Status With Survival in Patients After Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis. JAMA surgery, 151(10), 916-922. https://doi.org/10.1001/jamasurg.2016.1769

Greenblatt, D. Y., Kelly, K. J., Rajamanickam, V., Wan, Y., Hanson, T., Rettammel, R., . . . Weber, S. M. (2011). Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Annals of Surgical Oncology, 18(8), 2126-2135. https://doi.org/10.1245/s10434-011-1594-6

Groot Koerkamp, B., Wiggers, J. K., Allen, P. J., Besselink, M. G., Blumgart, L. H., Busch, O. R., . . . van Gulik, T. M. (2015). Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection. Journal of the American College of Surgeons, 221(6), 1041-1049. https://doi.org/10.1016/j.jamcollsurg.2015.09.005

Guglielmi, A., Ruzzenente, A., Bertuzzo, F., & Iacono, C. (2013). Assessment of nodal status for perihilar cholangiocarcinoma location, number, or ratio of involved nodes. Hepatobiliary surgery and nutrition, 2(5), 281-283. https://doi.org/10.3978/j.issn.2304-3881.2013.08.10

Hameed, A., Pang, T., Chiou, J., Pleass, H., Lam, V., Hollands, M., . . . Yuen, L. (2016). Percutaneous vs. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma - a systematic review and meta-analysis. HPB, 18(5), 400-410. https://doi.org/10.1016/j.hpb.2016.03.002

Hartog, H., Ijzermans, J. N., van Gulik, T. M., & Groot Koerkamp, B. (2016). Resection of Perihilar Cholangiocarcinoma. Surgical Clinics of North America, 96(2), 247-267. https://doi.org/10.1016/j.suc.2015.12.008

Helse- og omsorgsdepartementet. (2015). Nasjonal helse- og sykehusplan (2016−2019) (Meld. St. 11 (2015–2016)). Hentet fra https://www.regjeringen.no/contentassets/7b6ad7e0ef1a403d97958bcb34478609/no/pdfs/stm201520160011000dddpdfs.pdf

Hundal, R., & Shaffer, E. A. (2014). Gallbladder cancer: epidemiology and outcome. Clinical Epidemiology, 6, 99-109. https://doi.org/10.2147/clep.S37357

Ikeda, M., Nakachi, K., Konishi, M., Nomura, S., Katayama, H., Kataoka, T., . . . Furuse, J. (2022). Adjuvant S-1 versus observation in curatively resected biliary tract cancer: A phase III trial (JCOG1202: ASCOT). Journal of Clinical Oncology, 40(4_suppl), 382. https://doi.org/10.1200/JCO.2022.40.4_suppl.382

Izquierdo-Sanchez, L., Lamarca, A., La Casta, A., Buettner, S., Utpatel, K., Klümpen, H. J., . . . Banales, J. M. (2022). Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry. Journal of Hepatology, 76(5), 1109-1121. https://doi.org/10.1016/j.jhep.2021.12.010

Kamaya, A., Fung, C., Szpakowski, J. L., Fetzer, D. T., Walsh, A. J., Alimi, Y., . . . Middleton, W. D. (2022). Management of Incidentally Detected Gallbladder Polyps: Society of Radiologists in Ultrasound Consensus Conference Recommendations. Radiology, 305(2), 277-289. https://doi.org/10.1148/radiol.213079

Kelly, K. J., Dukleska, K., Kuk, D., Kingham, T. P., D'Angelica, M. I., DeMatteo, R. P., . . . Fong, Y. (2014). Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma. Annals of Surgical Oncology, 21(3), 979-985. https://doi.org/10.1245/s10434-013-3352-4

Kwon, H. J., Kim, S. G., Chun, J. M., Lee, W. K., & Hwang, Y. J. (2014). Prognostic factors in patients with middle and distal bile duct cancers. World Journal of Gastroenterology, 20(21), 6658-6665. https://doi.org/10.3748/wjg.v20.i21.6658

Kwon, W., Kim, H., Han, Y., Hwang, Y. J., Kim, S. G., Kwon, H. J., . . . Jang, J. Y. (2020). Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study. British Journal of Surgery, 107(10), 1334-1343. https://doi.org/10.1002/bjs.11618

Lang, H. (2021). Should all intrahepatic cholangiocarcinomas receive neoadjuvant chemotherapy before resection? British Journal of Surgery, 108(6), 598-599. https://doi.org/10.1093/bjs/znab077

Larsen, I. K. (red.). (2021). Cancer in Norway 2020: cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway. Hentet fra https://www.kreftregisteret.no/globalassets/cancer-in-norway/2020/cin-2020.pdf

Le Roy, B., Gelli, M., Pittau, G., Allard, M. A., Pereira, B., Serji, B., . . . Sa Cunha, A. (2018). Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma. British Journal of Surgery, 105(7), 839-847. https://doi.org/10.1002/bjs.10641

Lee, H., Choi, D. W., Park, J. Y., Youn, S., Kwon, W., Heo, J. S., . . . Jang, K. T. (2015). Surgical Strategy for T2 Gallbladder Cancer According to Tumor Location. Annals of Surgical Oncology, 22(8), 2779-2786. https://doi.org/10.1245/s10434-014-4300-7

Liang, B., Zhong, L., He, Q., Wang, S., Pan, Z., Wang, T., & Zhao, Y. (2015). Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Medical Science Monitor, 21, 3555-3563. https://doi.org/10.12659/msm.895040

Liang, L., Li, C., Wang, M. D., Xing, H., Diao, Y. K., Jia, H. D., . . . Yang, T. (2021). The value of lymphadenectomy in surgical resection of perihilar cholangiocarcinoma: a systematic review and meta-analysis. International Journal of Clinical Oncology, 26(9), 1575-1586. https://doi.org/10.1007/s10147-021-01967-z

Lov om pasient- og brukerrettigheter (pasient- og brukerrettighetsloven). (1999). LOV-1999-07-02-63. Hentet fra https://lovdata.no/dokument/NL/lov/1999-07-02-63

Luvira, V., Satitkarnmanee, E., Pugkhem, A., Kietpeerakool, C., Lumbiganon, P., & Pattanittum, P. (2021). Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma. Cochrane Database of Systematic Reviews, 9(9), CD012814. https://doi.org/10.1002/14651858.CD012814.pub2

Mansour, J. C., Aloia, T. A., Crane, C. H., Heimbach, J. K., Nagino, M., & Vauthey, J. N. (2015). Hilar cholangiocarcinoma: expert consensus statement. HPB, 17(8), 691-699. https://doi.org/10.1111/hpb.12450

Mantel, H. T., Westerkamp, A. C., Sieders, E., Peeters, P. M., de Jong, K. P., Boer, M. T., . . . Porte, R. J. (2016). Intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma is of limited value. Cancer medicine, 5(7), 1373-1380. https://doi.org/10.1002/cam4.693

Morine, Y., & Shimada, M. (2015). The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics. Journal of Gastroenterology, 50(9), 913-927. https://doi.org/10.1007/s00535-015-1071-2

Mosconi, C., Solaini, L., Vara, G., Brandi, N., Cappelli, A., Modestino, F., . . . Golfieri, R. (2021). Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis. Cardiovascular and Interventional Radiology, 44(5), 728-738. https://doi.org/10.1007/s00270-021-02800-w

Mosele, F., Remon, J., Mateo, J., Westphalen, C. B., Barlesi, F., Lolkema, M. P., . . . André, F. (2020). Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. Annals of Oncology, 31(11), 1491-1505. https://doi.org/10.1016/j.annonc.2020.07.014

Moustafa, M., Fasolo, E., Bassi, D., D'Amico F, E., Gringeri, E., Pawlik, T. M., & Cillo, U. (2020). The impact of liver resection on survival for locally advanced intrahepatic cholangiocarcinoma tumors: A propensity score analysis. European Journal of Surgical Oncology, 46(4 Pt A), 632-637. https://doi.org/10.1016/j.ejso.2019.11.502

Muraki, T., Pehlivanoglu, B., Memis, B., Reid, M. D., Uehara, T., Basturk, O., . . . Adsay, V. (2022). Pancreatobiliary Maljunction-associated Gallbladder Cancer Is as Common in the West, Shows Distinct Clinicopathologic Characteristics and Offers an Invaluable Model for Anatomy-induced Reflux-associated Physio-chemical Carcinogenesis. Annals of Surgery, 276(1), e32-e39. https://doi.org/10.1097/sla.0000000000004482

Oh, D. Y., Lee, K. H., Lee, D. W., Yoon, J., Kim, T. Y., Bang, J. H., . . . Kim, J. W. (2022). Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study. Lancet Gastroenterology & hepatology, 7(6), 522-532. https://doi.org/10.1016/s2468-1253(22)00043-7

Pestana, R. C., Sen, S., Hobbs, B. P., & Hong, D. S. (2020). Histology-agnostic drug development - considering issues beyond the tissue. Nature Reviews: Clinical Oncology, 17(9), 555-568. https://doi.org/10.1038/s41571-020-0384-0

Primrose, J. N., Fox, R. P., Palmer, D. H., Malik, H. Z., Prasad, R., Mirza, D., . . . Bridgewater, J. (2019). Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncology, 20(5), 663-673. https://doi.org/10.1016/s1470-2045(18)30915-x

Qadan, M., & Kingham, T. P. (2016). Technical Aspects of Gallbladder Cancer Surgery. Surgical Clinics of North America, 96(2), 229-245. https://doi.org/10.1016/j.suc.2015.12.007

Rassam, F., Roos, E., van Lienden, K. P., van Hooft, J. E., Klümpen, H. J., van Tienhoven, G., . . . van Gulik, T. M. (2018). Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience. Langenbecks Archives of Surgery, 403(3), 289-307. https://doi.org/10.1007/s00423-018-1649-2

Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. (2017). Journal of Hepatology, 66(6), 1265-1281. https://doi.org/10.1016/j.jhep.2017.02.013

Salazar, M., Ituarte, C., Abriata, M. G., Santoro, F., & Arroyo, G. (2019). Gallbladder cancer in South America: epidemiology and prevention. Chinese clinical oncology, 8(4), 32. https://doi.org/10.21037/cco.2019.07.12

Saluja, S. S., Sharma, R., Pal, S., Sahni, P., & Chattopadhyay, T. K. (2007). Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: a prospective study. HPB, 9(5), 373-382. https://doi.org/10.1080/13651820701504207

Schimizzi, G. V., Jin, L. X., Davidson, J. T. t., Krasnick, B. A., Ethun, C. G., Pawlik, T. M., . . . Fields, R. C. (2018). Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium. HPB, 20(4), 332-339. https://doi.org/10.1016/j.hpb.2017.10.003

Sekretariatet for nye metoder. (25. november 2022). Retningslinje for bruk av nye legemidler før markedsføringstillatelse (compassionate use). [nettressurs]. Hamar: nyemetoder.no. Hentet 28. november 2022, fra https://nyemetoder.no/om-systemet/retningslinje-for-bruk-av-nye-legemidler-for-markedsforingstillatelse-compassionate-use

Suthar, M., Purohit, S., Bhargav, V., & Goyal, P. (2015). Role of MRCP in Differentiation of Benign and Malignant Causes of Biliary Obstruction. Journal of clinical and diagnostic research : JCDR, 9(11), Tc08-12. https://doi.org/10.7860/jcdr/2015/14174.6771

Suzuki, S., Shimoda, M., Shimazaki, J., Maruyama, T., Oshiro, Y., Nishida, K., . . . Harada, N. (2019). Number of positive lymph nodes and lymphatic invasion are significant prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma. Clinical and Experimental Gastroenterology, 12, 255-262. https://doi.org/10.2147/ceg.S207333

Søreide, K., Guest, R. V., Harrison, E. M., Kendall, T. J., Garden, O. J., & Wigmore, S. J. (2019). Systematic review of management of incidental gallbladder cancer after cholecystectomy. British Journal of Surgery, 106(1), 32-45. https://doi.org/10.1002/bjs.11035

Ten Hove, A., de Meijer, V. E., Hulscher, J. B. F., & de Kleine, R. H. J. (2018). Meta-analysis of risk of developing malignancy in congenital choledochal malformation. British Journal of Surgery, 105(5), 482-490. https://doi.org/10.1002/bjs.10798

Tirotta, F., Giovinazzo, F., Hodson, J., Yates, L., Tan, D., Salsano, M., . . . Sutcliffe, R. (2020). Risk factors to differentiate between benign proximal biliary strictures and perihilar cholangiocarcinoma. HPB, 22(12), 1753-1758. https://doi.org/10.1016/j.hpb.2020.03.023

Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., . . . Bridgewater, J. (2010). Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. New England Journal of Medicine, 362(14), 1273-1281. https://doi.org/10.1056/NEJMoa0908721

Valle, J. W., Kelley, R. K., Nervi, B., Oh, D. Y., & Zhu, A. X. (2021). Biliary tract cancer. Lancet, 397(10272), 428-444. https://doi.org/10.1016/s0140-6736(21)00153-7

Van Eecke, E., Degroote, H., Vanlander, A., & Hindryckx, P. (2022). Outcome of primary ERCP versus primary PTC for biliary drainage in malignant hilar biliary strictures: a systematic review and meta-analysis. Surgical Endoscopy, 36(10), 7160-7170. https://doi.org/10.1007/s00464-022-09413-5

van Keulen, A. M., Buettner, S., Besselink, M. G., Busch, O. R., van Gulik, T. M., Ijzermans, J. N. M., . . . Olthof, P. B. (2021). Surgical morbidity in the first year after resection for perihilar cholangiocarcinoma. HPB, 23(10), 1607-1614. https://doi.org/10.1016/j.hpb.2021.03.016

van Vugt, J. L. A., Gaspersz, M. P., Coelen, R. J. S., Vugts, J., Labeur, T. A., de Jonge, J., . . . Groot Koerkamp, B. (2018). The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma. HPB, 20(1), 83-92. https://doi.org/10.1016/j.hpb.2017.08.025

Weber, S. M., Ribero, D., O'Reilly, E. M., Kokudo, N., Miyazaki, M., & Pawlik, T. M. (2015). Intrahepatic cholangiocarcinoma: expert consensus statement. HPB, 17(8), 669-680. https://doi.org/10.1111/hpb.12441

Weismüller, T. J., Trivedi, P. J., Bergquist, A., Imam, M., Lenzen, H., Ponsioen, C. Y., . . . Boberg, K. M. (2017). Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. Gastroenterology, 152(8), 1975-1984.e1978. https://doi.org/10.1053/j.gastro.2017.02.038

Wernberg, J. A., & Lucarelli, D. D. (2014). Gallbladder cancer. Surgical Clinics of North America, 94(2), 343-360. https://doi.org/10.1016/j.suc.2014.01.009

Wiggers, J. K., Groot Koerkamp, B., Cieslak, K. P., Doussot, A., van Klaveren, D., Allen, P. J., . . . Jarnagin, W. R. (2016). Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant. Journal of the American College of Surgeons, 223(2), 321-331.e321. https://doi.org/10.1016/j.jamcollsurg.2016.03.035

Zhang, X. F., Chakedis, J., Bagante, F., Chen, Q., Beal, E. W., Lv, Y., . . . Pawlik, T. M. (2018). Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma. British Journal of Surgery, 105(7), 857-866. https://doi.org/10.1002/bjs.10827

Zhou, R., Lu, D., Li, W., Tan, W., Zhu, S., Chen, X., . . . Chen, Y. (2019). Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. HPB, 21(7), 784-792. https://doi.org/10.1016/j.hpb.2018.12.011

Zhu, A. X., Macarulla, T., Javle, M. M., Kelley, R. K., Lubner, S. J., Adeva, J., . . . Abou-Alfa, G. K. (2021). Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial. JAMA oncology, 7(11), 1669-1677. https://doi.org/10.1001/jamaoncol.2021.3836